Highbury Investment Pte Ltd - Net Worth and Insider Trading

Highbury Investment Pte Ltd Net Worth

The estimated net worth of Highbury Investment Pte Ltd is at least $146 Million dollars as of 2024-06-21. Highbury Investment Pte Ltd is the 2101 Beneficial owner of Shanghai Junshi Biosciences Co Ltd and owns about 12,918,902 shares of Shanghai Junshi Biosciences Co Ltd (HKSE:01877) stock worth over $146 Million. Details can be seen in Highbury Investment Pte Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Highbury Investment Pte Ltd has not made any transactions after 2024-03-04 and currently still holds the listed stock(s).

Transaction Summary of Highbury Investment Pte Ltd

Highbury Investment Pte Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Highbury Investment Pte Ltd owns 1 companies in total, including Shanghai Junshi Biosciences Co Ltd (HKSE:01877) .

Click here to see the complete history of Highbury Investment Pte Ltd’s form 4 insider trades.

Insider Ownership Summary of Highbury Investment Pte Ltd

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:01877	Shanghai Junshi Biosciences Co Ltd	2024-03-04	2101 Beneficial owner

Highbury Investment Pte Ltd Latest Holdings Summary

Highbury Investment Pte Ltd currently owns a total of 1 stock. Highbury Investment Pte Ltd owns 12,918,902 shares of Shanghai Junshi Biosciences Co Ltd (HKSE:01877) as of March 4, 2024, with a value of $146 Million.

Latest Holdings of Highbury Investment Pte Ltd

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:01877	Shanghai Junshi Biosciences Co Ltd	2024-03-04	12,918,902	11.28	145,725,215

Holding Weightings of Highbury Investment Pte Ltd

Highbury Investment Pte Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Highbury Investment Pte Ltd has made a total of 4 transactions in Shanghai Junshi Biosciences Co Ltd (HKSE:01877) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Shanghai Junshi Biosciences Co Ltd is the sale of 260,800 shares on March 4, 2024, which brought Highbury Investment Pte Ltd around $3 Million.

Insider Trading History of Highbury Investment Pte Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Highbury Investment Pte Ltd Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Highbury Investment Pte Ltd Ownership Network

Ownership Network List of Highbury Investment Pte Ltd

No Data

Ownership Network Relation of Highbury Investment Pte Ltd

Highbury Investment Pte Ltd Owned Company Details

What does Shanghai Junshi Biosciences Co Ltd do?

Who are the key executives at Shanghai Junshi Biosciences Co Ltd?

Highbury Investment Pte Ltd is the 2101 Beneficial owner of Shanghai Junshi Biosciences Co Ltd. Other key executives at Shanghai Junshi Biosciences Co Ltd include 2201 Interest of corporation controlled by you Gic (ventures) Pte. Ltd. , 2102 Investment manager Gic Special Investments Private Limited , and 2201 Interest of corporation controlled by you Gic Private Limited .

Shanghai Junshi Biosciences Co Ltd (HKSE:01877) Insider Trades Summary

Over the past 18 months, Highbury Investment Pte Ltd made no insider transaction in Shanghai Junshi Biosciences Co Ltd (HKSE:01877). Other recent insider transactions involving Shanghai Junshi Biosciences Co Ltd (HKSE:01877) include a net sale of 3,428,600 shares made by Gong Ruilin , a net sale of 3,428,600 shares made by Lin Lijun , and a net sale of 3,428,600 shares made by Vistra Trust (singapore) Pte. Limited .

In summary, during the past 3 months, insiders sold 0 shares of Shanghai Junshi Biosciences Co Ltd (HKSE:01877) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 30,051,200 shares of Shanghai Junshi Biosciences Co Ltd (HKSE:01877) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 29,451,200 shares.

Shanghai Junshi Biosciences Co Ltd (HKSE:01877)'s detailed insider trading history can be found in Insider Trading Tracker table.

Shanghai Junshi Biosciences Co Ltd Insider Transactions

No Available Data

Highbury Investment Pte Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Highbury Investment Pte Ltd. Currently GuruFocus does not have mailing address information for Highbury Investment Pte Ltd.

Discussions on Highbury Investment Pte Ltd

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.